Autophagy, ISSN 1554-8627, 04/2012, Volume 8, Issue 4, pp. 445 - 544
In 2008 we published the first set of guidelines for standardizing research in autophagy. Since then, research on this topic has continued to accelerate, and...
stress | vacuole | autolysosome | flux | LC3 | autophagosome | lysosome | phagophore | Binding | Proteins | Landes | Calcium | Bioscience | Biology | Cell | Cycle | Cancer | Organogenesis | Phagophore | Lysosome | Autolysosome | Flux | Autophagosome | Vacuole | Stress | ACTIVATED PROTEIN-KINASE | CHAPERONE-MEDIATED AUTOPHAGY | VACUOLE TARGETING PATHWAY | ENDOPLASMIC-RETICULUM STRESS | ISOLATED RAT HEPATOCYTES | STARVATION-INDUCED AUTOPHAGY | GLUCAGON-INDUCED AUTOPHAGY | CELL BIOLOGY | PROGRAMMED CELL-DEATH | BREAST-CANCER CELLS | BETAINE HOMOCYSTEINE METHYLTRANSFERASE | Biological Assay - methods | Animals | Autophagy - genetics | Models, Biological | Humans | Life Sciences | Cellular Biology | Review | Medical and Health Sciences | Medicin och hälsovetenskap
stress | vacuole | autolysosome | flux | LC3 | autophagosome | lysosome | phagophore | Binding | Proteins | Landes | Calcium | Bioscience | Biology | Cell | Cycle | Cancer | Organogenesis | Phagophore | Lysosome | Autolysosome | Flux | Autophagosome | Vacuole | Stress | ACTIVATED PROTEIN-KINASE | CHAPERONE-MEDIATED AUTOPHAGY | VACUOLE TARGETING PATHWAY | ENDOPLASMIC-RETICULUM STRESS | ISOLATED RAT HEPATOCYTES | STARVATION-INDUCED AUTOPHAGY | GLUCAGON-INDUCED AUTOPHAGY | CELL BIOLOGY | PROGRAMMED CELL-DEATH | BREAST-CANCER CELLS | BETAINE HOMOCYSTEINE METHYLTRANSFERASE | Biological Assay - methods | Animals | Autophagy - genetics | Models, Biological | Humans | Life Sciences | Cellular Biology | Review | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
1994, ISBN 0827349637, xxi, 388
Book
MOLECULES, ISSN 1420-3049, 05/2019, Volume 24, Issue 10, p. 1855
Peptides constitute molecular diversity with unique molecular mechanisms of action that are proven indispensable in the management of many human diseases, but...
peptide | EXPRESSING LHRH RECEPTORS | DRUG CONJUGATE | mixed-mode pharmacology | GLP-1 | CYTOTOXIC ANALOGS | BIOCHEMISTRY & MOLECULAR BIOLOGY | peptide-drug conjugate | chemical linker | CHEMISTRY, MULTIDISCIPLINARY | 1ST-IN-MAN PHASE-I | PS 2 PATIENTS | LHRH | COMPARING PACLITAXEL POLIGLUMEX | drug discovery | IN-VITRO EVALUATION | RADIONUCLIDE THERAPY | THYROID-HORMONE REGULATION | cancer | CALCITONIN-RECEPTOR AGONIST | GnRH | diabetes | obesity | Index Medicus
peptide | EXPRESSING LHRH RECEPTORS | DRUG CONJUGATE | mixed-mode pharmacology | GLP-1 | CYTOTOXIC ANALOGS | BIOCHEMISTRY & MOLECULAR BIOLOGY | peptide-drug conjugate | chemical linker | CHEMISTRY, MULTIDISCIPLINARY | 1ST-IN-MAN PHASE-I | PS 2 PATIENTS | LHRH | COMPARING PACLITAXEL POLIGLUMEX | drug discovery | IN-VITRO EVALUATION | RADIONUCLIDE THERAPY | THYROID-HORMONE REGULATION | cancer | CALCITONIN-RECEPTOR AGONIST | GnRH | diabetes | obesity | Index Medicus
Journal Article
Psychological Inquiry, ISSN 1047-840X, 1/2004, Volume 15, Issue 3, pp. 197 - 215
Emotional states | Emotional expression | Intelligence | Emotional intelligence | Psychometrics | Target Articles | Cognition | Emotion | Emotion theories | Personality psychology | Intelligence quotient | PERSONALITY | POSITIVE AFFECT | TESTS | PSYCHOLOGY, MULTIDISCIPLINARY | ABILITY | SYSTEMS | PREDICTIVE-VALIDITY | SCALE | ALEXITHYMIA | INDIVIDUAL-PERFORMANCE | TRADITIONAL STANDARDS
Journal Article
5.
Full Text
The Chemical Methods of Disulfide Bond Formation and Their Applications to Drug Conjugates
Current Organic Chemistry, ISSN 1385-2728, 12/2019, Volume 23
: The disulfide bond possesses unique chemical and biophysical properties which distinguish it as one of the key structural elements of bioactive proteins and...
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2019, Volume 380, Issue 4, pp. 347 - 357
In a randomized trial of patients with type 2 diabetes, treatment with dapagliflozin, an SGLT2 inhibitor that promotes glucosuria, did not result in a higher...
2013 ACCF/AHA GUIDELINE | MEDICINE, GENERAL & INTERNAL | SELECTIVE SGLT2 INHIBITOR | MANAGEMENT | HEART-FAILURE OUTCOMES | DISEASE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | KIDNEY | EMPAGLIFLOZIN | SOCIETY | Type 2 diabetes | Safety and security measures | Dapagliflozin | Dosage and administration | Drug therapy | Cardiovascular diseases | Risk factors | Heart failure | Myocardial infarction | Cerebral infarction | End-stage renal disease | Heart attacks | Mortality | Diabetes mellitus | Cardiovascular disease | FDA approval | Patients | Glomerular filtration rate | Heart rate | Ischemia | Sodium | Arteriosclerosis | Ketoacidosis | Death | Diabetes | Kidney diseases | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Cardiovascular Diseases | drug therapy | Benzhydryl Compounds | complications | Humans | Middle Aged | Male | Sodium-Glucose Transporter 2 Inhibitors | Hospitalization | prevention & control | Klinisk medicin | Diabetes Mellitus | etiology | Clinical Medicine | epidemiology | statistics & numerical data | adverse effects | mortality | Type 2 | Heart Failure | Female | Aged | therapeutic use | Glucosides
2013 ACCF/AHA GUIDELINE | MEDICINE, GENERAL & INTERNAL | SELECTIVE SGLT2 INHIBITOR | MANAGEMENT | HEART-FAILURE OUTCOMES | DISEASE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | KIDNEY | EMPAGLIFLOZIN | SOCIETY | Type 2 diabetes | Safety and security measures | Dapagliflozin | Dosage and administration | Drug therapy | Cardiovascular diseases | Risk factors | Heart failure | Myocardial infarction | Cerebral infarction | End-stage renal disease | Heart attacks | Mortality | Diabetes mellitus | Cardiovascular disease | FDA approval | Patients | Glomerular filtration rate | Heart rate | Ischemia | Sodium | Arteriosclerosis | Ketoacidosis | Death | Diabetes | Kidney diseases | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Cardiovascular Diseases | drug therapy | Benzhydryl Compounds | complications | Humans | Middle Aged | Male | Sodium-Glucose Transporter 2 Inhibitors | Hospitalization | prevention & control | Klinisk medicin | Diabetes Mellitus | etiology | Clinical Medicine | epidemiology | statistics & numerical data | adverse effects | mortality | Type 2 | Heart Failure | Female | Aged | therapeutic use | Glucosides
Journal Article